SLFN11 and small cell lung carcinoma: Although one study did report SLFN11 expression to be associated with a better response to TMZ/PARPi combination treatment in SCLC patients, a very low cut-off value for SLFN11 expression was used (any presence of SLFN11-positive cells) (Pietanza et al. 2018).